Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet
- PMID: 20233938
- PMCID: PMC2886525
- DOI: 10.1152/ajpendo.00033.2010
Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet
Abstract
Hepatic ketogenesis provides a vital systemic fuel during fasting because ketone bodies are oxidized by most peripheral tissues and, unlike glucose, can be synthesized from fatty acids via mitochondrial beta-oxidation. Since dysfunctional mitochondrial fat oxidation may be a cofactor in insulin-resistant tissue, the objective of this study was to determine whether diet-induced insulin resistance in mice results in impaired in vivo hepatic fat oxidation secondary to defects in ketogenesis. Ketone turnover (micromol/min) in the conscious and unrestrained mouse was responsive to induction and diminution of hepatic fat oxidation, as indicated by an eightfold rise during the fed (0.50+/-0.1)-to-fasted (3.8+/-0.2) transition and a dramatic blunting of fasting ketone turnover in PPARalpha(-/-) mice (1.0+/-0.1). C57BL/6 mice made obese and insulin resistant by high-fat feeding for 8 wk had normal expression of genes that regulate hepatic fat oxidation, whereas 16 wk on the diet induced expression of these genes and stimulated the function of hepatic mitochondrial fat oxidation, as indicated by a 40% induction of fasting ketogenesis and a twofold rise in short-chain acylcarnitines. Together, these findings indicate a progressive adaptation of hepatic ketogenesis during high-fat feeding, resulting in increased hepatic fat oxidation after 16 wk of a high-fat diet. We conclude that mitochondrial fat oxidation is stimulated rather than impaired during the initiation of hepatic insulin resistance in mice.
Figures






Similar articles
-
Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1. Obesity (Silver Spring). 2010. PMID: 19798065
-
Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.Am J Physiol Endocrinol Metab. 2014 Jul 15;307(2):E176-85. doi: 10.1152/ajpendo.00087.2014. Epub 2014 May 27. Am J Physiol Endocrinol Metab. 2014. PMID: 24865983 Free PMC article.
-
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E484-94. doi: 10.1152/ajpendo.00492.2015. Epub 2016 Jan 26. Am J Physiol Endocrinol Metab. 2016. PMID: 26814015 Free PMC article.
-
Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting.Trends Endocrinol Metab. 2024 Feb;35(2):107-124. doi: 10.1016/j.tem.2023.10.002. Epub 2023 Nov 6. Trends Endocrinol Metab. 2024. PMID: 37940485 Review.
-
Hepatic ketogenesis and peripheral ketone body utilization in the ruminant.J Nutr. 1987 Jun;117(6):1174-80. doi: 10.1093/jn/117.6.1174. J Nutr. 1987. PMID: 3298582 Review.
Cited by
-
Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.J Lipid Res. 2012 Jun;53(6):1080-92. doi: 10.1194/jlr.M023382. Epub 2012 Apr 9. J Lipid Res. 2012. PMID: 22493093 Free PMC article.
-
Chronic voluntary wheel running exercise ameliorates metabolic dysfunction via PGC-1α expression independently of FNDC5/irisin pathway in high fat diet-induced obese mice.J Physiol Sci. 2023 Apr 11;73(1):6. doi: 10.1186/s12576-023-00864-6. J Physiol Sci. 2023. PMID: 37041517 Free PMC article.
-
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.Front Physiol. 2022 Jul 4;13:946474. doi: 10.3389/fphys.2022.946474. eCollection 2022. Front Physiol. 2022. PMID: 35860662 Free PMC article. Review.
-
Determination of ketone bodies in biological samples via rapid UPLC-MS/MS.Talanta. 2021 Apr 1;225:122048. doi: 10.1016/j.talanta.2020.122048. Epub 2020 Dec 25. Talanta. 2021. PMID: 33592770 Free PMC article.
-
Discrepancy of Beta-Hydroxybutyrate Measurements between a Blood Meter and GC-MS Methods in Healthy Humans.Muscles. 2023 Sep 27;2(4):327-337. doi: 10.3390/muscles2040025. Muscles. 2023. PMID: 40757529 Free PMC article.
References
-
- An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI, Koves TR, Stevens R, Millington D, Newgard CB. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10: 268–274, 2004 - PubMed
-
- Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5: 426–437, 2007 - PubMed
-
- Bailey JW, Haymond MW, Miles JM. Validation of two-pool model for in vivo ketone body kinetics. Am J Physiol Endocrinol Metab 258: E850–E855, 1990 - PubMed
-
- Balasse EO, Neef MA. Inhibition of ketogenesis by ketone bodies in fasting humans. Metabolism 24: 999–1007, 1975. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases